Treatment Education
General peptide education
What peptides are, how they are regulated, and why sourcing matters.
Clinical services are not available yet. GetPeptides has not launched medical visits, prescriptions or pharmacy delivery in any state. Nothing you do here enrolls you in treatment.
Educational information only — not medical advice. A consultation with a licensed clinician never guarantees a prescription, and treatment decisions are made independently between you and your clinician.
This page is editorial content written by the GetPeptides team from the publicly available regulatory sources cited below. It has not been reviewed or approved by a qualified independent clinician or pharmacist, and it is not medical advice.
What peptides are
Peptides are short chains of amino acids. In the body, many act as signaling molecules that bind receptors and influence biological processes. What a peptide does depends entirely on which peptide it is and how it is used.
How they are regulated
Some peptides are FDA-approved drugs. Others are available only as compounded preparations made under section 503A or 503B, which are not FDA-approved. Many discussed online are unapproved or investigational and are not legal to sell for human use.
Why sourcing matters
Quality, purity and potency vary widely outside regulated channels. Products labeled 'research use only' are not manufactured or tested for human use and may be contaminated, mislabeled or incorrectly dosed.
The role of clinicians and pharmacies
A licensed clinician evaluates whether treatment is appropriate for a given patient. If a prescription is written, a licensed pharmacy dispenses and ships the medication.
Risks and limitations
No peptide is risk-free. Side effects, interactions and contraindications are individual. Educational information here is not medical advice and never replaces an evaluation.
Sources
- FDA: Compounding and the FDA — Questions and Answers — editorial source list 2026-10-14
- FDA: FD&C Act Provisions that Apply to Human Drug Compounding (sections 503A and 503B) — editorial source list 2026-10-14